Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Bioinformatic strategies for unambiguous identification of prostate specific antigen in clinical samples

Författare

Summary, in English

Prostate specific antigen (PSA), as a widely used clinical biomarker in prostate cancer

diagnostics, exists in multiple molecular forms. However, all of these forms might not be recognized in

a given sample by the standard immunoassays. Therefore, we have investigated PSA isoforms

separated by size using mass spectrometric analyses. The objective of these developments was to

identify and specify the various forms of PSA. To optimize successful identification of different PSA

forms, we have developed a bioinformatic strategy, consisting of high resolution MALDI-MS PMF and

sequencing MS/MS data searches. To improve sequence-based identification, the recently introduced

Proteios software environment was employed, allowing the combination of multiple database search

engines in an automated manner.

We could unambiguously identify PSA in clinical samples by all detectable tryptic peptides, which were

found to be common in several isoforms.

Ämne

  • Cancer and Oncology
  • Medicinal Chemistry

Nyckelord

  • prostate specific antigen
  • isoforms
  • MALDI LTQ Orbitrap XL
  • ESI-LTQ FT-ICR
  • Proteios software environment
  • kallikrein-2

Status

Published

Forskningsgrupp

  • Clinical Chemistry, Malmö

ISBN/ISSN/Övrigt

  • ISSN: 1874-3919